
AstraZeneca buys conjugate vaccine developer Omniose
Omniose is to be acquired by AstraZeneca, following a productive three-year exclusive research collaboration between the two companies. Under the terms of the agreement, Omniose has become a wholly owned subsidiary of AstraZeneca and a part of the Infectious Disease Unit. The acquisition brings Omniose’s… Read More















